Records containing: Pelvic Inflammatory Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23A Comparison of Acute Toxicities Between Patients Treated With Protons or Intensity-Modulated Radiation Therapy for Post-Operative Treatment of Endometrial or Cervical Cancers
-
CLINICAL_TRIALS study record update · 2025-11-14Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID
-
CLINICAL_TRIALS study record update · 2025-05-25Effect of an Anti-inflammatory Diet on the Nutritional Status and Cytokine Expression of Patients With Locally Advanced Cervical Cancer: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-01-03The Diagnostic Utility of Ultrasound in Pelvic Inflammatory Disease (PID)
-
CLINICAL_TRIALS study record update · 2024-04-11A Randomized Controlled Trial on the Clinical Efficacy and Safety of Warm Meridians and Relieve Pain Plaster in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain (Cold Dampness Stasis Type).
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-21Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
-
CLINICAL_TRIALS study record update · 2023-12-12Rate of Pelvic Inflammatory Disease and Tubo-ovarian Abscess at SMH
-
CLINICAL_TRIALS study record update · 2023-04-04A Randomized, Double-blind, Positive-Controlled Study to Evaluate the Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
-
CLINICAL_TRIALS study record update · 2022-12-13Factors Associated With an Unfavorable Clinical Course in Hospitalized Patients With Pelvic Inflammatory Disease in Post Covid 19 Era: a Multicentric Retrospective Cohort Study
-
CLINICAL_TRIALS study record update · 2022-01-04Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity
-
CLINICAL_TRIALS study record update · 2019-03-27Randomized, Placebo-controlled, Double-blind Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of Increasing Single Oral Doses of BAY1834845 Including Relative Bioavailability of a Liquid Versus a Solid Dosage in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2018-01-05An Open-Lable Multicenter Prospective Non-Randomized Trial to Assess the Efficacy and Safety of Morinidazole With Levofloxacin and Sequential of Levofloxacin in Women With Pelvic Inflammatory Disease
-
CLINICAL_TRIALS study record update · 2017-10-26Randomized Trial of Laparoscopic Versus Abdominal Hysterectomy for Benign Indications and Impact on Surgical Success
-
CLINICAL_TRIALS study record update · 2017-04-26Drug Use Investigation Of Azithromycin Iv
-
CLINICAL_TRIALS study record update · 2016-12-21The Importance of Anti-anaerobic Therapy for Acute PID
-
CLINICAL_TRIALS study record update · 2016-11-23Clinical Promotion Research of Complex Treatment With TCM to Diagnosis and Treatment on Different Syndrome Types of Pelvic Inflammatory Disease Sequelae
-
CLINICAL_TRIALS study record update · 2016-08-17Characterization of Novel Organisms in the Genital Tract of Women With PID and Determination of Their Association With Endometritis.
-
CLINICAL_TRIALS study record update · 2014-11-24Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
-
CLINICAL_TRIALS study record update · 2014-10-28Improving Primary Care Follow-up for Adolescents With PID: A Randomized Controlled Trial Using Text Message Reminders
-
CLINICAL_TRIALS study record update · 2014-10-15Prospective, Randomized, Double-blind, Multicenter, Multinational Study Comparing Efficacy and Safety of Moxifloxacin 400 mg po od for 14 Days With Ofloxacin 400 mg po Bid Plus Metronidazole 500 mg po Bid for 14 Days in Patients With Uncomplicated Pelvic Inflammatory Disease (PID)
-
CLINICAL_TRIALS study record update · 2013-08-28ClinicalTrials.gov study NCT01799356
-
CLINICAL_TRIALS study record update · 2011-11-03A Multicenter, Non-Randomized, Open Label Study Of Azithromycin Intravenous Followed By Oral Administration In Japanese Adult Subjects With Pelvic Inflammatory Disease (PID) Requiring Initial Intravenous Therapy
-
CLINICAL_TRIALS study record update · 2010-11-16Phase 4 Study of Azitromicin in the Treatment of PID
-
CLINICAL_TRIALS study record update · 2009-11-30A Prospective, Randomized, Double Dummy, Double Blind, Multi-center Multinational Trial Comparing the Efficacy and Safety of Moxifloxacin 400 mg PO QD 24 Hours for 14 Days to That of Levofloxacin 500 mg PO QD 24 Hours Plus Metronidazole 500 mg BID for 14 Days in Subjects With an Uncomplicated Pelvic Inflammatory Disease (PID). Moxifloxacin, Metronidazole, and Levofloxacin in Asia (MONALISA Study)